Journal of acquired immune deficiency syndromes (1999)HumansHeterocyclic Compounds3-RingPyridonesUganda
Low Levels of Clinically Significant Drug Resistance Mutations to Dolutegravir Among Children Living with HIV Failing on First-Line Antiretroviral Therapy in Uganda.
Eleanor N Magongo, Marisa Hast, Vennie Nabitaka, Miriam Nakanwagi, Evarist Twinomujjuni, Stephanie Dowling, George Senyama, Brian Nzano, Mary Alwano, Jane Nakaweesi, Esther Nazziwa, Grace Namayanja, Esther Nkolo, Alisen Ayitewala, Stephanie Hackett
Published: 202610.1097/QAI.0000000000003784
Abstract
BACKGROUND: Introduction of pediatric-friendly dolutegravir (DTG) formulations to treat children living with HIV (CLHIV) has presented new opportunities to improve viral suppression; however, there are limited data on emerging patterns of HIV drug re…
Preview only. Read the full abstract at the source